biotech

Folgen

A billionaire-backed biotech startup, R3 Bio, is developing genetically engineered 'organ sacks'—whole organ systems without a brain—as an alternative to animal testing. This idea comes as the Trump administration phases out animal experimentation across the federal government. A cofounder states the long-term goal is to create human versions.

Von KI berichtet

Science Corporation, a brain-computer interface startup founded by former Neuralink president Max Hodak, has announced a new division focused on extending the viability of human organs for transplantation. The company unveiled a prototype machine designed to preserve organs for longer periods. This initiative expands beyond their core work in neural technology.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen